BACKGROUND: Carbon dioxide decreases halothane minimum alveolar concentrations (MAC) in dogs when Paco 2 exceeds 95 mm Hg. We sought to confirm these findings for several potent inhaled anesthetics in rats. METHODS: Groups of eight rats were anesthetized with halothane, isoflurane, or desflurane. MAC was determined for each anesthetic alone, and then with increasing concentrations of inspired CO 2 . A fourth group was given CO 2 alone to determine the MAC of CO 2 . RESULTS: Increasing inspired CO 2 concentrations produced a linear dose-dependent decrease in MAC of each potent inhaled anesthetic. With elimination of CO 2 , the MAC of isoflurane and desflurane returned to the original MAC. As determined by extrapolating these data to 0% of the inhaled anesthetic, the MAC of CO 2 was approximately 50% of 1 atm. Given alone, CO 2 proved lethal. CONCLUSIONS: Unlike dogs, no threshold for the CO 2 -MAC response arose with halothane, isoflurane, or desflurane in rats. The ED 50 for CO 2 is also approximately 50% greater in rats than reported in dogs.
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(Anesth Analg 2007;105: Theanest hetic effects of CO 2 have long been recognized (1) . Although CO 2 acts as an "inhaled" anesthetic, the mechanism mediating CO 2 narcosis may differ from that underlying anesthesia produced by conventional inhaled anesthetics. For example, the potent anesthetics isoflurane and halothane exhibit additivity; that is, administration of half an isoflurane minimum alveolar concentration (MAC) (the MAC of inhaled anesthetic required to suppress movement in response to noxious stimulation in 50% of subjects) plus half a halothane MAC produces the same percent immobilization as either anesthetic alone at MAC (2). In contrast, increasing Paco 2 to 95 mm Hg in dogs does not significantly decrease halothane MAC (3). And hypocapnia in humans (4) or dogs (3) does not increase halothane MAC. Increases in CO 2 exceeding 95 mm Hg decrease halothane MAC in a dosedependent manner to zero at 245 mm Hg CO 2 (3). The absence of a change in MAC with increasing CO 2 partial pressures up to 95 mm Hg suggests a mechanism of action for CO 2 that differs from that underlying halothane.
However, studies using end-points other than MAC have detected anesthetic effects from mild CO 2 perturbations. In humans, hypocapnia increases the partial pressure of nitrous oxide required to produce incoordination and unconsciousness, and mild hypercapnia (Paco 2 ϭ 50 -60 mm Hg) decreases the concentration of nitrous oxide needed to sustain consciousness (5) . There is no CO 2 threshold for either effect. Normal human subjects breathing CO 2 concentrations up to 10% exhibit impaired dexterity and mental acuity; still larger inspired concentrations cause unconsciousness (6) . Recently, unpublished observations from our laboratory suggest that moderate hypercapnia in rats might reduce the isoflurane concentration required for immobility. Therefore, the anesthetic-sparing effects of CO 2 might depend on the species, phenotype, drug, and anesthetic end-point studied.
We hypothesized that if narcotic effects of CO 2 were mechanistically similar in all species, then increasing Pco 2 in rats should yield the threshold effect seen dogs, and that CO 2 should not be additive with MAC for any volatile anesthetic. The present work tested these hypotheses.
METHODS
We used 32 adult male Sprague-Dawley rats weighing 314 Ϯ 48 g (mean Ϯ sd) obtained from Charles River Laboratories (Hollister, CA). Husbandry before experiments included commercial rat chow and water available ad libitum and a 12-h light-dark cycle. We conducted four separate anesthetic (MAC) studies of the response to CO 2 , each with eight rats, using either halothane, isoflurane, desflurane, or CO 2 alone as the anesthetic. Each rat was studied only once. The Animal Use and Care Committee at the University of CA, San Francisco approved this protocol.
A description of the anesthetic delivery apparatus and MAC determination techniques used in this study has been published (7). Briefly, 8.8 ϫ 25 cm cylindrical Plexiglas chambers were connected in parallel each receiving gas through a one-holed rubber stopper from an agent-specific and temperature-compensated vaporizer. The fresh gas flow rate was Ն1 L ⅐ min Ϫ1 ⅐ cylinder
Ϫ1
. A needle capped with a stopcock pierced each stopper, permitting gas sampling from the tube. The other end of each Plexiglas chamber was sealed with a two-holed stopper; rat tails were drawn through one hole and a passive gas scavenging system was attached to the second hole. A thermistor probe also traversed a sealed portion of the two-holed stopper to measure rectal temperature, which was maintained at 37°C Ϯ 1°C using heating pads as needed.
Rats then were exposed to a sub-MAC concentration of the study anesthetic delivered in 100% oxygen for approximately 45 min, after which movement in response to 60-s tail clamping was assessed. Concentrations of inspired anesthetic were measured by gas chromatography (GOW-MAC Series 580, Bridgewater, NJ) using a 4.6-m, 0.22-cm internal diameter SF-96 packed column maintained at 100°C and a flame ionization detector maintained at 150°C. The chromatograph was calibrated before and several times during each experiment with anesthetic gas standards; linearity of the detector was confirmed using dilutions of the gas standards. After tail clamping and gas sampling, the anesthetic concentration was increased by 15%-20% of a normal MAC for that anesthetic and held constant for 30 min to allow equilibration between inspired and alveolar partial pressures (7). Response to tail clamp was reassessed and gas concentration was again measured by gas chromatography. This was repeated with 30 min equilibration for each change in anesthetic concentration until all rats were immobile in response to tail clamping. The arithmetic mean of the anesthetic concentrations that bracketed move/no move responses defined individual MAC values (8) . At this point, a certified CO 2 gas standard in oxygen replaced the O 2 carrier gas (Airgas, Sacramento, CA) and the inspired anesthetic concentration was decreased until all animals moved. MAC was then determined for the anesthetic in CO 2 as previously described. Tanks containing progressively higher certified concentrations of CO 2 (10.8%, 20.9%, 31.4%, 41.8%, 51.6%, 63.2%) were used and MAC retested until immobility was achieved in all rats with no addition of a volatile anesthetic. Most CO 2 carrier gas concentrations were studied in combination with all anesthetics. Finally, MAC for the anesthetic alone (no CO 2 ) in 100% O 2 carrier gas was remeasured to verify the reversibility of the effect of CO 2 on anesthetic requirement.
In a separate experiment, direct CO 2 MAC measurement was attempted in eight rats. After placement in the plexiglass cylinder as previously described, 51.6% CO 2 in O 2 was acutely administered to all rats in the absence of a volatile anesthetic. Subsequent MAC testing was not possible because of the development of pulmonary edema in most animals.
During CO 2 inhalation, Pico 2 was used to approximate Paco 2 because rats were not instrumented to obtain end-tidal or arterial gas samples. However, in the absence of neuromuscular impairment or fatigue, alveolar ventilation increases in proportion to inspired CO 2 fraction. The inspired-to-arterial CO 2 difference is less than 10 mm Hg in rats breathing gas mixtures containing Ն5% CO 2 (9) . Even at light planes of anesthesia, Pico 2 under these conditions provides a reasonable estimate of Paco 2 (10) .
Descriptive data are presented as mean Ϯ sd. To compare CO 2 effects among anesthetics, anesthetic ED 50 for each rat was calculated as a MAC fraction by dividing the MAC for anesthetic plus CO 2 by the MAC for the anesthetic alone for that rat. The effect of Fico 2 on MAC fraction was analyzed using least squares linear regression (SPSS, v.11, Chicago, IL). A one-sided paired t-test was used to determine whether the post-CO 2 MAC determination was less than the pre-CO 2 MAC determination for any of the three volatile anesthetics (an indication of injury from prolonged hypercapnia). t-Tests with Dunn-Sidak corrections for multiple comparisons were used to determine significant differences among MAC for all three anesthetics administered in 100% O 2 (no CO 2 ) and 10% CO 2 . Differences were considered significant if P Ͻ 0.05.
RESULTS
MAC values for halothane, isoflurane, and desflurane (mean Ϯ sd) were 1.14% Ϯ 0.11%, 1.42% Ϯ 0.10%, and 7.21% Ϯ 0.63% atm, respectively. Addition of CO 2 rectilinearly and significantly decreased MAC of all anesthetics. For each 10% increase in Fico 2 , anesthetic requirement for all anesthetics decreased approximately 20%. No threshold response was observed (Fig.  1) . MAC values for each anesthetic administered in 10% CO 2 were significantly different than MAC measurements made with 100% O 2 carrier gas. The duration of each experiment was approximately 8 -10 h.
Although CO 2 -MAC response curves are essentially colinear for the three anesthetics, there were differences did at higher Fico 2 . The halothane-CO 2 response for the eight rats appears to deviate from the other anesthetics at the x-intercept (Fig. 1) . However, two rats given halothane developed labored breathing and died after this measurement. MAC of halothane administered in O 2 at the end of the study in the remaining six animals (repeat of control MAC) was 0.93% Ϯ 0.18%, a statistically significant difference that was 18% lower than the measurement preceding CO 2 exposure (P Ͻ 0.05). MAC values for isoflurane and desflurane at the end of each experiment were 1.37% Ϯ 0.26% and 6.90% Ϯ 0.84%, respectively; these values are statistically indistinguishable from measurements made before CO 2 exposure.
Our attempt to measure MAC of CO 2 in the absence of a volatile anesthetic was unsuccessful. The acute exposure of eight rats to 40% CO 2 in O 2 produced dyspnea and fulminant pulmonary edema within 10 -15 min. However, direct measurement of CO 2 MAC for rats in the desflurane group was 49% Ϯ 5% atm. Extrapolation of the isoflurane data predicted a CO 2 MAC of 54% atm.
A pooled regression analysis for all data points for all anesthetics, excluding the erroneous halothane x-intercept during the measurement of which rats developed pulmonary edema, is described by the following equation: %MAC ϭ Ϫ1.9 ϫ Fico 2 ϩ 1.0, where %MAC is the percent decrease in ED 50 for the volatile anesthetic and Fico 2 is the fraction inspired carbon dioxide. This relationship has a correlation coefficient of Ϫ0.99 and predicts CO 2 MAC to be 53% atm.
DISCUSSION
In conflict with our hypotheses, CO 2 linearly and progressively decreased the anesthetizing (MAC) concentrations of conventional inhaled anesthetics, abolishing the need for continued inhaled anesthetic administration to produce immobility at 0.53 atm CO 2 . For desflurane and isoflurane, the effect of increasing Fico 2 was reversible; the MAC on removal of the increased Fico 2 equaled that before administration of CO 2 .
The finding of a rectilinear decrease in MAC in rats with increasing Fico 2 contrasts with results from dogs. In dogs, Paco 2 Ͻ95 mm Hg did not significantly decrease halothane MAC, although the average MAC was less than the control MAC (3). Measurement of end-tidal halothane and CO 2 versus the present study measurement of inspired concentrations would not appear to explain the difference in findings, particularly for desflurane. Given the poor solubility of desflurane, the inspired-to-end-tidal difference should be minimal (11) . Further to this point, an increase in Fico 2 increases minute ventilation, even in anesthetized rats (12, 13) , and reduces dead-space ventilation; both these factors should additionally minimize differences between inspired and alveolar CO 2 and anesthetic tensions (14) . Respiration of 10% inspired CO 2 does not increase alveolar CO 2 by 10% of an atmosphere. Were the application of 10% CO 2 to quadruple ventilation in the absence of increased metabolism, PaCO 2 would equal approximately 80 mm Hg. In evidence, measurements in anesthetized rats rebreathing CO 2 up to 70 mm Hg demonstrate that Pico 2 closely approximates Paco 2 (10) . Thus, the gas sampled (end-tidal versus inspired) does not explain the response differences between dogs and rats. Other reasons for this discrepancy include species differences to CO 2 narcosis or underestimation of the control canine MAC. Given the rat responses reported here, it may be of value to verify dog CO 2 threshold and MAC measurements using the identical methods from this study.
MAC data for the volatile anesthetics in this study confirm values previously reported (7, 15) . MAC for CO 2 is approximately 50% higher in the rat than in the dog. Why the rat should be less sensitive to the anesthetic effects of CO 2 than the dog is unclear. As burrowing animals, rats could be exposed in nature to CO 2 inspired fractions approaching 10% (16); decreased sensitivity to the anesthetic effects of CO 2 might therefore provide an important physiologic adaptation. Tolerance to CO 2 when awake may also help explain the tendency for rats anesthetized at 1.0 times MAC to hypoventilate more than dogs that are similarly anesthetized (17, 18) .
Based on solubility in oil (19), CO 2 is approximately three times more potent in the rat than predicted by 21) for conventional anesthetics (22) . The basis for the greater narcotic effect is not clear, but Eisle et al., suggested that it was associated with the capacity of CO 2 to decrease extracellular pH (3).
We could not measure MAC of CO 2 without first anesthetizing the animals. CO 2 increases arterial blood pressure indirectly by increasing circulating catecholamines and angiotensin II (23) . Perhaps these effects of CO 2 , combined with excitement of anesthetic induction, caused pulmonary hypertension leading to pulmonary edema.
Halothane combined with CO 2 proved toxic at larger CO 2 concentrations. Compared to contemporary haloether anesthetics, halothane produces more depression of left ventricular output (24) and possibly more pulmonary vasoconstriction (25) . These changes could increase mean pulmonary arterial pressure and exacerbate pulmonary hypertension caused by severe hypercapnia, contributing to the CO 2 toxicity we observed.
The linear relationship between CO 2 concentration and volatile anesthetic concentrations (Fig. 1) also describes an isobologram, with points for all anesthetics lying on the line of additivity. If additivity between conventional anesthetic MAC values is consistent with (albeit, not proof of) a common site of action (2) , then the same may also hold true for combinations of conventional anesthetics and CO 2 .
Distinctions between dogs and rats with respect to CO 2 potency and additivity with other conventional anesthetics suggest that either there may be different anesthetic-sensitive targets in different species, or the common anesthetic targets in different species may vary substantially in their sensitivity to inhaled anesthetics. In comparisons with previous studies, differences in anesthetic potency between dogs and rats appear much larger for CO 2 than for halothane (8) , isoflurane (26) , or desflurane (27) . Perhaps this reflects greater species variation in primary target site(s) for CO 2 narcosis than for sites responsible for volatile anesthetic action.
Finally, one might ask whether humans resemble dogs or rats in their response to CO 2 . If the response of humans parallels that of dogs, then patients with chronically increased CO 2 values Ͻ95 mm Hg may be awake at, and seriously discomfited by, such increased values. However, if patient responses are those of the rat, then the increased CO 2 will produce an element of anesthesia, an effect that might decrease the discomfort of such elevated levels of CO 2 . This also implies that the increased concentrations of CO 2 seen during anesthesia in humans could contribute to anesthesia. Yet, whether humans might be more like rats or dogs in this respect remains, at present, a topic for phylogenetic (28, 29) and philosophic debate.
